Thrombocytopenia in liver disease
Authors:
- Edoardo G GianniniEdoardo G Giannini
- Vincenzo SavarinoVSVincenzo Savarino
- 1 September 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Hematology
- Vol. 15 (5) , 473-480
Abstract
To evaluate recent findings in the multifaceted pathophysiological mechanisms underlying thrombocytopenia in patients with chronic liver disease and to assess its therapeutic management. Antiplatelet antibodies, despite being observed rather frequently in patients with chronic viral liver disease, have minimal relevance in the determinism of thrombocytopenia, and antiviral treatment of the underlying liver disease does not seem to significantly affect their prevalence. Translational application of the results of studies evaluating coagulation disorders associated with liver disease seems to suggest that these may be improved by treating thrombocytopenia. Both splenectomy and partial splenic embolization are still part of the therapeutic approach to thrombocytopenia. As far as this latter technique is concerned, patient selection is fundamental, and its success likely depends upon thrombopoietin-mediated mechanisms. Eltrombopag is a promising thrombopoietic drug that proved to be able to safely increase platelet counts in patients with viral liver disease and allows the initiation of antiviral treatment. New insights into the pathophysiological mechanisms of thrombocytopenia in patients with liver disease have provided interesting clinical reflex. In these patients, novel therapies for treating thrombocytopenia seem promising, although it remains to be established whether treating thrombocytopenia may help improve liver disease-associated coagulopathy.Keywords
This publication has 43 references indexed in Scilit:
- New thrombopoietic growth factorsBlood, 2007
- Evaluation of platelet kinetics in patients with liver cirrhosis: Similarity to idiopathic thrombocytopenic purpuraJournal of Gastroenterology and Hepatology, 2006
- Platelet autoantibodies are common in hepatitis C infection, irrespective of the presence of thrombocytopeniaEuropean Journal of Haematology, 2006
- Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment optionsAlimentary Pharmacology & Therapeutics, 2006
- Is there an increased frequency of autoimmune thrombocytopenia in hepatitis C infection? A review.Wiener Medizinische Wochenschrift, 2003
- Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infectionAmerican Journal of Gastroenterology, 2002
- Thrombocytopenia in Liver DiseaseCanadian Journal of Gastroenterology and Hepatology, 1999
- Evaluation of Thrombopoiesis in Thrombocytopenic Disorders by Simultaneous Measurement of Reticulated Platelets of Whole Blood and Serum Thrombopoietin ConcentrationsThrombosis and Haemostasis, 1998
- Platelet autoantibodies in patients with chronic liver diseaseAmerican Journal of Hematology, 1995
- Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia.Journal of Clinical Investigation, 1966